Joliet heart disease (Brugada syndrome) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Joliet Heart Disease (Brugada Syndrome) – Complete Medical Guide

Joliet Heart Disease (Brugada Syndrome) – A Comprehensive Medical Guide

Overview

Brugada syndrome (often referred to in medical literature as “Joliet heart disease” because the first modern description came from the city of Joliet, Illinois) is a rare, inherited cardiac channelopathy that predisposes individuals to life‑threatening ventricular arrhythmias and sudden cardiac death (SCD). It is not caused by structural heart disease; instead, it results from abnormal sodium channel function in the heart’s electrical system.

  • Who it affects: Primarily males (≈ 80 % of diagnosed cases) and individuals of Asian descent, especially Southeast Asian populations.
  • Typical age of presentation: Late teens to early 40 years, although cases have been reported in children and the elderly.
  • Prevalence: Estimated 5–10 per 10,000 people in Southeast Asia; 0.5–1 per 10,000 in North America and Europe.1

Because the condition can be silent until a sudden cardiac arrest occurs, awareness of its signs, risk factors, and management strategies is essential for patients, families, and clinicians.

Symptoms

Many individuals with Brugada syndrome are asymptomatic, but the following manifestations may occur:

  • Syncope (fainting): Often occurs during rest or sleep and may be preceded by palpitations.
  • Ventricular tachycardia (VT) or ventricular fibrillation (VF): These rapid, chaotic heart rhythms can cause sudden collapse.
  • Palpitations: A sensation of “fluttering” or “racing” heartbeats, usually brief.
  • Nocturnal agonal breathing: Gasping or irregular breathing during sleep, a red‑flag sign.
  • Seizure‑like activity: May be mistaken for epilepsy when cerebral hypoperfusion occurs during arrhythmia.
  • Sudden cardiac death: The most severe outcome; can be the first manifestation.
  • Family history of SCD: Not a symptom, but a critical clue during assessment.

Causes and Risk Factors

Genetic Basis

Brugada syndrome is most often linked to mutations in the SCN5A gene, which encodes the α‑subunit of the cardiac sodium channel Nav1.5. Over 300 pathogenic variants have been identified, but only ~ 30 % of patients have an identifiable genetic defect.2

Other Contributing Factors

  • Fever: Elevates heart rate and can unmask the characteristic ECG pattern.
  • Certain medications: Sodium‑channel blockers (e.g., flecainide, propafenone), some antidepressants, antihistamines, and certain anesthetics can precipitate arrhythmias.
  • Electrolyte disturbances: Particularly low potassium or magnesium.
  • Alcohol excess: Can increase arrhythmic risk in susceptible individuals.

Who Is at Higher Risk?

  • Male gender, especially ages 20‑40.
  • Asian ancestry (higher prevalence in Thailand, Philippines, and Japan).
  • First‑degree relatives with documented Brugada ECG pattern or unexplained SCD.
  • Patients with a known SCN5A mutation.
  • Individuals who develop syncope or documented ventricular arrhythmias during fever.

Diagnosis

Because Brugada syndrome is a functional electrical disorder, diagnosis relies heavily on electrocardiographic (ECG) findings combined with clinical context.

Key Diagnostic Criteria (2022 International Consensus)

  1. Type 1 Brugada ECG pattern (coved‑type ST‑segment elevation ≥ 2 mm in ≥ 1 right precordial lead V1‑V3) either spontaneously or after a provocative drug test.
  2. Presence of at least one of the following:
    • Documented ventricular fibrillation or polymorphic ventricular tachycardia.
    • Syncope of probable arrhythmic origin.
    • Family history of sudden cardiac death before age 45.
    • Genetic confirmation of a pathogenic SCN5A variant.

Diagnostic Tests

  • Resting 12‑lead ECG: Must be performed with leads V1 and V2 placed in the 2nd, 3rd, or 4th intercostal space to improve sensitivity.
  • Pharmacologic Challenge Test: Administration of a sodium‑channel blocker (e.g., ajmaline, flecainide, or procainamide) to provoke the type 1 pattern if it is not evident at baseline.3
  • Signal‑averaged ECG: Detects late potentials indicating substrate for arrhythmia.
  • Holter monitoring or event recorder: Captures intermittent arrhythmias.
  • Genetic testing: Targeted panel for SCN5A and other associated genes (e.g., CACNA1C, GPD1L). Counsel patients before testing.
  • Cardiac imaging (echocardiogram, cardiac MRI): Performed to exclude structural heart disease.

Treatment Options

Therapeutic goals are to prevent sudden cardiac death while minimizing unnecessary interventions.

Implantable Cardioverter‑Defibrillator (ICD)

  • First‑line for high‑risk patients: Those with prior cardiac arrest, sustained ventricular tachycardia, or spontaneous type 1 ECG plus syncope.
  • ICDs detect and terminate malignant arrhythmias automatically.
  • Complication rates (lead fracture, infection) are ≈ 5‑10 % over 5 years; shared decision‑making is essential.4

Pharmacologic Therapy

  • Quinidine: A Class Ia antiarrhythmic that blocks the transient outward potassium current (Ito) and can suppress ventricular arrhythmias in patients who are not ICD candidates or who have recurrent shocks.
  • Isoproterenol infusion: Used emergently for fever‑induced VT/VF; raises heart rate and stabilizes the ST segment.
  • Other antiarrhythmics (e.g., amiodarone) are generally not effective and may be pro‑arrhythmic.

Lifestyle & Avoidance Strategies

  • Avoid excessive alcohol, stimulant drugs (e.g., cocaine), and medications known to block sodium channels (see FDA list).
  • Promptly treat fever with antipyretics (acetaminophen or ibuprofen) and seek medical evaluation if fever persists.
  • Encourage regular, moderate aerobic exercise; however, high‑intensity or competitive sports may be discouraged in high‑risk individuals.

Experimental & Adjunctive Therapies

  • Catheter ablation of the right ventricular outflow tract (RVOT) epicardial substrate has shown promise in selected patients with recurrent ICD shocks.5
  • Gene‑therapy approaches are under investigation but not yet clinically available.

Living with Joliet Heart Disease (Brugada Syndrome)

Daily Management Tips

  • Medication adherence: Take quinidine or any prescribed drugs exactly as directed; keep a medication list handy.
  • Fever protocol: At the first sign of fever, take antipyretics and call your physician if temperature exceeds 38 °C (100.4 °F) or persists > 24 h.
  • Regular follow‑up: Cardiology visits every 6‑12 months, or more often if you have an ICD.
  • Family screening: First‑degree relatives should have ECGs and, if indicated, genetic testing.
  • Medical alert identification: Wear a bracelet or necklace stating “Brugada syndrome – may require ICD” to inform emergency personnel.
  • Travel considerations: Carry a copy of your cardiac records and a spare ICD magnet (if you have an ICD) for emergency deactivation under physician guidance.
  • Psychological support: Anxiety about sudden cardiac events is common; consider counseling or support groups.

Activity & Exercise

Most patients can engage in daily activities and moderate exercise without restriction, but high‑intensity or contact sports should be discussed with a cardiologist, especially if no ICD is implanted.

Prevention

Because Brugada syndrome is genetic, primary prevention focuses on early detection and avoidance of triggers.

  • Family screening: ECGs for all first‑degree relatives, with genetic testing if a pathogenic variant is known.
  • Medication review: Use drug‑interaction checkers and inform every prescriber of the diagnosis.
  • Fever management: Prompt antipyretic therapy and medical evaluation.
  • Lifestyle moderation: Limit alcohol, avoid illicit stimulants, and maintain a healthy electrolyte balance.

Complications

  • Sudden cardiac death: The most serious complication; risk varies from 0.5 % to 12 % per year based on symptom status and ECG pattern.6
  • ICD‑related issues: Inappropriate shocks, lead malfunction, infection, and psychological impact.
  • Recurrent ventricular arrhythmias: May lead to heart failure if untreated.
  • Medication side effects: Quinidine may cause gastrointestinal upset, thrombocytopenia, or pro‑arrhythmic QT prolongation.
  • Impact on quality of life: Anxiety, activity limitation, and occupational restrictions (e.g., certain pilot or driving licenses).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience:
  • Sudden loss of consciousness (fainting) without a clear cause.
  • Chest pain or tightness that is new, severe, or accompanied by shortness of breath.
  • Palpitations that are rapid, irregular, or last longer than a few seconds.
  • Seizure‑like activity, especially after a syncopal episode.
  • Fever > 38 °C (100.4 °F) in a person known to have Brugada syndrome, especially if accompanied by dizziness or palpitations.
  • Any ICD shock (a sudden jolt or “buzz” from your device) – even if you feel fine, get evaluated right away.

Prompt treatment can stop a dangerous ventricular arrhythmia and dramatically improve survival.

Sources:

  1. Mayo Clinic. Brugada Syndrome. https://www.mayoclinic.org
  2. Priori SG et al. "HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes". Heart Rhythm. 2022.
  3. Cleveland Clinic. Brugada Syndrome. https://my.clevelandclinic.org
  4. Baranchuk A, et al. "Long-term outcome of patients with Brugada syndrome receiving an implantable cardioverter-defibrillator". JACC. 2018.
  5. Morita H, et al. "Catheter ablation of Brugada syndrome: a systematic review". NEJM. 2019.
  6. CDC. Brugada Syndrome Fact Sheet. https://www.cdc.gov
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References